Source:http://linkedlifedata.com/resource/pubmed/id/16215717
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
2006-4-28
|
pubmed:abstractText |
A target tumor-derived whole cancer cell therapeutic vaccine was developed based on an in vitro pre-treatment by photodynamic therapy (PDT) and was investigated using a poorly immunogenic tumor model. The vaccine was produced by incubating in vitro expanded mouse squamous cell carcinoma SCCVII cells for 1 h with photosensitizer benzoporphyrin derivative (BPD), then exposing to light (690 nm, 1 J/cm2) and finally to a lethal X-ray dose. Treatment of established subcutaneous SCCVII tumors growing in syngeneic C3H/HeN mice with 2 x 10(7) PDT-vaccine cells per mouse by a peritumoral injection produced a significant therapeutic effect, including growth retardation, regression and cures. Tumor specificity of this PDT-generated vaccine was demonstrated by its ineffectiveness when prepared from a mismatched tumor cell line. Vaccine cells retrieved from the treatment site at 1 h postinjection were intermixed with dendritic cells (DC), exhibited heat shock protein 70 on their surface, and were opsonized by complement C3. Tumor-draining lymph nodes treated by the PDT-vaccine contained dramatically increased numbers of DC as well as B and T lymphocytes (with enlarged memory phenotype fraction in the latter), while high levels of surface-bound C3 were detectable on DC and to a lesser extent on B cells. The PDT-vaccine produced no therapeutic benefit against tumors growing in C3-deficient hosts. It is suggested that surface expression of heat shock proteins and complement opsonization are the two unique features of PDT-treated cells securing avid immune recognition of vaccinated tumor and the development of a strong and effective antitumor adaptive immune response.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Cancer Vaccines,
http://linkedlifedata.com/resource/pubmed/chemical/Complement C3,
http://linkedlifedata.com/resource/pubmed/chemical/HSP70 Heat-Shock Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Photosensitizing Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Porphyrins,
http://linkedlifedata.com/resource/pubmed/chemical/benzoporphyrin D
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0340-7004
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
55
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
900-9
|
pubmed:meshHeading |
pubmed-meshheading:16215717-Animals,
pubmed-meshheading:16215717-Cancer Vaccines,
pubmed-meshheading:16215717-Carcinoma, Lewis Lung,
pubmed-meshheading:16215717-Carcinoma, Squamous Cell,
pubmed-meshheading:16215717-Complement C3,
pubmed-meshheading:16215717-Dendritic Cells,
pubmed-meshheading:16215717-Flow Cytometry,
pubmed-meshheading:16215717-HSP70 Heat-Shock Proteins,
pubmed-meshheading:16215717-Mice,
pubmed-meshheading:16215717-Mice, Knockout,
pubmed-meshheading:16215717-Neoplasm Transplantation,
pubmed-meshheading:16215717-Photochemotherapy,
pubmed-meshheading:16215717-Photosensitizing Agents,
pubmed-meshheading:16215717-Porphyrins
|
pubmed:year |
2006
|
pubmed:articleTitle |
Photodynamic therapy-generated vaccine for cancer therapy.
|
pubmed:affiliation |
British Columbia Cancer Agency, 675 West 10th Avenue, Vancouver, V5Z 1L3, BC, Canada. mkorbelik@bccrc.ca
|
pubmed:publicationType |
Journal Article,
In Vitro,
Research Support, Non-U.S. Gov't
|